Showing results (1-10 of 1,370) with videos related to

Sort By:
Pageof 137
Drug Development Research|November 11, 2014
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerationsBarbara Marinari, Elisabetta Botti, Mauro Bavetta, et al.
Drug Development Research|November 11, 2014
Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic patients treated with etanerceptAlessandro Giunta, Graziella Babino, Sara Manetta, et al.
Drug Development Research|November 11, 2014
Treatment adherence to different etanercept regimens, continuous vs. intermittent, in patients affected by plaque-type psoriasisMaria Esposito, Paolo Gisondi, Nicoletta Cassano, et al.
Drug Development Research|November 11, 2014
Monoclonal gammopathy of undetermined significance in patients with psoriasis: is it really a side effect of biological therapy?Andrea Conti, Ilaria Esposito, Claudia Lasagni, et al.
Drug Development Research|November 11, 2014
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patientsEleonora Ballanti, Paola Conigliaro, Maria Sole Chimenti, et al.
Drug Development Research|November 11, 2014
Periodontal disease: an oral manifestation of psoriasis or an occasional finding?Giulia Ganzetti, Anna Campanati, Andrea Santarelli, et al.
Drug Development Research|November 11, 2014
Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasisStefano Piaserico, Elena Sandini, Alda Saldan, et al.
Drug Development Research|December 3, 2014
Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury modelSiyu Guan, Qizhu Tang, Wenwei Liu, et al.
Drug Development Research|August 19, 2015
miRNAs as Biomarkers in Chronic Myelogenous LeukemiaKasuen Kotagama, Yung Chang, Marco Mangone
Drug Development Research|April 27, 2016
Isorhamnetin-3-O-Glucuronide Suppresses JNK and p38 Activation and Increases Heme-Oxygenase-1 in Lipopolysaccharide-Challenged RAW264.7 CellsJin-Young Park, Song-In Kim, Hee Jae Lee, et al.
Pageof 137